Recent Advances in the Treatment, Management and Prevention of Obesity

A continuing medical education activity provided by NAMCP and AAMCN

This activity is an archive from the live session from the 2021 Fall Managed Care Forum.
If you participated in the live session, you are not eligible for continuing
education credits from this archive.

This activity is valid from January 1, 2022, to March 1, 2023.

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.


Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from
Novo Nordisk

Obesity is a health care epidemic and one of the major drivers of health care costs in the United States. Excess adiposity affects most organ systems and obesity is linked to a wide range of comorbidities, including hypertension, type 2 diabetes, heart disease, and certain cancers. When aggregated across payers, obesity accounts for approximately 9.1% of total medical expenditures. Approximately 70% of adults in the US have obesity or are overweight. Obesity has been shown to be a risk factor for a number of fatal conditions, such as coronary heart disease, type 2 diabetes, hypertension, stroke, and certain types of cancer. Losing between 5% and 10% of body weight has been associated with a reduced risk of cardiovascular disease in obese or overweight adults. This activity will focus on the newest information on recent and upcoming medications for obesity to help improve patient education and lifestyle changes to reduce the risk of obesity and their associated comorbidities.

Upon completion of this activity, participants will be able to:

  • Examine appropriate methods for long term risk assessment for patients with obesity

  • Analyze novel treatment therapies for patients with obesity, including advanced pharmacological approaches and bariatric surgery options

  • Describe personalized treatment plans that include lifestyle changes, behavior modification, and nutrition and physical activity plans

  • Examine the multidisciplinary roles for teams that manage obesity to overcome the challenges associated with the disease

  • Discuss managed care considerations for treating obesity, including a look at the direct and indirect costs surrounding obesity management


Faculty: Ken Fujioka, MD
Founding Director of Center for Weight Management
Director of the Nutrition and Metabolic Research Center
Scripps Clinic, Dept. of Diabetes and Endocrine


Dr. Fujioka serves as a consultant for Amgen, Boehringer Ingelheim, Gelesis, Janssen, Novo Nordisk, Phenomix, Takeda, and Sunovion. He has serves on the speaker's bureau for Novo Nordisk and Takeda. His presentation has been reviewed for any bias.
Planning Committee: Bill Williams, MD has no financial relationships with ineligible companies to disclose.
Jeremy Williams has no financial relationships with ineligible companies to disclose.
Jacqueline Cole, RN, MS, CMCN has no financial relationships with ineligible companies to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association of Managed Care Physicians (NAMCP) and American Association of Managed Care Nurses (AAMCN). The National Association of Managed Care Physicians is accredited by the ACCME to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in nursing continuing professional development.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This activity is supported by an educational grant from
Novo Nordisk

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue